Skip to main content
Andreas Rimner, MD, Radiation Oncology, New York, NY

AndreasRimnerMD

Radiation Oncology New York, NY

Thoracic Cancer

Associate Attending

Dr. Rimner is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Rimner's full profile

Already have an account?

  • Office

    Memorial Sloan Kettering Cancer Center New York
    1275 York Avenue
    New York, NY 10021

Education & Training

  • Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer CenterResidency, Radiation Oncology, 2006 - 2010
  • Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer CenterInternship, Transitional Year, 2005 - 2006
  • Eberhard Karls University Faculty of Medicine
    Eberhard Karls University Faculty of MedicineClass of 2003

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2023 - Present
  • NY State Medical License
    NY State Medical License 2010 - 2026
  • NJ State Medical License
    NJ State Medical License 2022 - 2025
  • American Board of Radiology Radiation Oncology

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Design and Validation of a MV/kV Imaging Based Markerless Tracking System for Assessing Real Time Lung Tumor Motion  
    Andreas Rimner, MD, Medical Physics
  • Stereotactic Body Radiation Therapy (SBRT) Improves Local Control and Overall Survival Compared to Conventionally Fractionated Radiation for Stage I Non-Small Cell Lun...  
    Kenneth E Rosenzweig, Fauzia Shaikh, Daphna Y Gelblum, Shaun U Din, Andreas Rimner, Abraham J Wu, Acta Oncologica

Authored Content

  • The Expanding Role of Radiation Therapy for Thymic MalignanciesNovember 2017

Press Mentions

  • Local Therapy Extends Use of Targeted Drugs in Oligoprogressive Lung Cancer
    Local Therapy Extends Use of Targeted Drugs in Oligoprogressive Lung CancerOctober 20th, 2022
  • Treatment Planning and Outcomes Effects of Reducing the Preferred Mean Esophagus Dose for Conventionally Fractionated Non‐Small Cell Lung Cancer Radiotherapy
    Treatment Planning and Outcomes Effects of Reducing the Preferred Mean Esophagus Dose for Conventionally Fractionated Non‐Small Cell Lung Cancer RadiotherapyJanuary 25th, 2021
  • The Expanding Role of Radiation Therapy for Thymic Malignancies
    The Expanding Role of Radiation Therapy for Thymic MalignanciesSeptember 3rd, 2020
  • Join now to see all